Shu-Wha Lin

Professor
Department of Clinical Laboratory Science and Medical Biotechnology, National Taiwan University
Taipei, Taipei, Taiwan (Republic of China)

Presentation(s):

• OC 41.5 - Evaluation of factor VIII inhibitor risk under emicizumab prophylaxis using hemophilia A murine models with long-term expression of human factors IX and X

  Monday, June 24, 2024
  15:45 – 16:00 ICT